Century Therapeutics, Inc. (IPSC)
IPSC Stock Price Chart
Explore Century Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze IPSC price movements and trends.
IPSC Company Profile
Discover essential business fundamentals and corporate details for Century Therapeutics, Inc. (IPSC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Jun 2021
Employees
140.00
Website
https://www.centurytx.comCEO
Brent Pfeiffenberger
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
IPSC Financial Timeline
Browse a chronological timeline of Century Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.37.
Earnings released on 14 Aug 2025
EPS came in at -$0.38 matching the estimated -$0.38.
Earnings released on 15 May 2025
EPS came in at $0.89 surpassing the estimated -$0.31 by +387.10%, while revenue for the quarter reached $109.16M , beating expectations by +164.37%.
Earnings released on 19 Mar 2025
EPS came in at -$0.43 surpassing the estimated -$0.45 by +4.44%, while revenue for the quarter reached $4.17M , missing expectations by -91.58%.
Earnings released on 5 Nov 2024
EPS came in at -$0.37 surpassing the estimated -$0.46 by +19.57%, while revenue for the quarter reached $791.00K , beating expectations by +79.77%.
Earnings released on 8 Aug 2024
EPS came in at -$0.38 surpassing the estimated -$0.50 by +24.00%, while revenue for the quarter reached $771.00K , beating expectations by +79.30%.
Earnings released on 9 May 2024
EPS came in at -$0.45 surpassing the estimated -$0.50 by +10.00%, while revenue for the quarter reached $855.00K , beating expectations by +307.14%.
Earnings released on 14 Mar 2024
EPS came in at -$0.49 surpassing the estimated -$0.56 by +12.50%, while revenue for the quarter reached $268.00K , missing expectations by -83.94%.
Earnings released on 9 Nov 2023
EPS came in at -$0.55 falling short of the estimated -$0.53 by -3.77%, while revenue for the quarter reached $148.00K , missing expectations by -88.76%.
Earnings released on 9 Aug 2023
EPS came in at -$0.56 falling short of the estimated -$0.54 by -3.70%, while revenue for the quarter reached $99.00K , missing expectations by -91.33%.
Earnings released on 11 May 2023
EPS came in at -$0.53 matching the estimated -$0.53, while revenue for the quarter reached $1.72M , beating expectations by +16.71%.
Earnings released on 16 Mar 2023
EPS came in at -$0.55 surpassing the estimated -$0.59 by +6.78%, while revenue for the quarter reached $521.00K , missing expectations by -73.99%.
Earnings released on 10 Nov 2022
EPS came in at -$0.53 surpassing the estimated -$0.59 by +10.17%, while revenue for the quarter reached $2.22M , beating expectations by +105.45%.
Earnings released on 11 Aug 2022
EPS came in at -$0.54 falling short of the estimated -$0.50 by -8.00%, while revenue for the quarter reached $1.40M , beating expectations by +4.33%.
Earnings released on 16 May 2022
EPS came in at -$0.66 falling short of the estimated -$0.45 by -46.67%, while revenue for the quarter reached $1.06M , missing expectations by -89.42%.
Earnings released on 17 Mar 2022
EPS came in at -$0.24 surpassing the estimated -$0.46 by +47.83%.
Earnings released on 10 Nov 2021
EPS came in at -$0.48 falling short of the estimated -$0.40 by -20.00%.
Earnings released on 12 Aug 2021
EPS came in at -$1.93 falling short of the estimated -$0.42 by -359.52%.
Earnings released on 21 Jun 2021
EPS came in at -$0.37 .
Earnings released on 31 Mar 2021
EPS came in at -$0.33 .
Earnings released on 30 Sept 2020
EPS came in at -$0.31 .
IPSC Stock Performance
Access detailed IPSC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.